Updated just now · Live
Stock analysis, price data, and AI-powered insights for Sutro Biopharma Inc (STRO).
Sutro Biopharma Inc operates in the Biotechnology sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for STRO.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). STRO Stock Intelligence Report. [stoxpulse.com/stocks/stro]
Disclaimer: The information on this page about Sutro Biopharma Inc (STRO) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Sutro Biopharma Inc.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
Sutro Biopharma Presents Promising Preclinical Dat...
1d ago
Reported Sunday, Sutro Biopharma's STRO-004 Demons...
1d ago
StoxPulse AI results for STRO: Pulse Score 53/100. Primary sentiment trends from 3 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$572.9M
P/E Ratio
—
EPS
$-0.67
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Sutro Biopharma Presents Promising Preclinical Data Across Its Pipeline of Next-Generation Single and Dual-Payload Adc Programs
Reported Sunday, Sutro Biopharma's STRO-004 Demonstrates Robust Antitumor Activity Across TF-Expressing Solid Tumor PDX Models With Improved Efficacy Versus Benchmark ADCs At AACR 2026
Citizens Maintains Market Outperform on Sutro Biopharma, Raises Price Target to $35